Literature DB >> 25564257

IgG4-related ophthalmic disease. Part I: background and pathology.

Alan A McNab1, Penny McKelvie.   

Abstract

PURPOSE: To review the current state of knowledge of IgG4-related ophthalmic disease (IgG4-ROD).
METHODS: A review of the literature and personal experience of the authors.
RESULTS: IgG4-related disease is a recently recognized fibroinflammatory disorder that may affect 1 or more organs. It is characterized by lymphoplasmacytic infiltrates with large numbers of IgG4 positive plasma cells, storiform fibrosis, obliterative phlebitis, and eosinophil infiltration as well as peripheral eosinophilia, and in some cases, elevated serum levels of IgG4. These features are not always seen, and the diagnosis should be made by integrating clinical, imaging, and histopathological data, with reference to recently defined diagnostic criteria. IgG4-ROD forms a significant proportion of what has previously been labeled "idiopathic orbital inflammation" or reactive lymphoid hyperplasia. Orbital disease may occur alone, at the same time as disease elsewhere, or metachronously with systemic disease. Although almost any ocular adnexal tissue may be affected, there are several more common recognizable patterns of IgG4-ROD: 1) sclerosing dacryoadenitis; 2) enlargement of orbital nerves (most commonly the infraorbital nerve) associated with orbital myositis and lacrimal gland disease, often in combination with paranasal sinus disease, eosinophilia, and systemic involvement; and 3) sclerosing orbital inflammation.
CONCLUSIONS: Patients presenting with orbital inflammatory lesions should have biopsies obtained whenever possible. The examining pathologist should routinely look for features of IgG4-ROD, and if found, the patient should be investigated for other organ involvement. Early treatment may prevent destructive changes in affected tissues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25564257     DOI: 10.1097/IOP.0000000000000363

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  11 in total

1.  A 10-year review of orbital biopsy: the Newcastle Eye Centre Study.

Authors:  D S J Ting; M Perez-Lopez; N J Chew; L Clarke; A J Dickinson; C Neoh
Journal:  Eye (Lond)       Date:  2015-06-05       Impact factor: 3.775

Review 2.  Immunology of IgG4-related disease.

Authors:  E Della-Torre; M Lanzillotta; C Doglioni
Journal:  Clin Exp Immunol       Date:  2015-06-08       Impact factor: 4.330

3.  Painful ophthalmoplaegia secondary to orbital myositis.

Authors:  Jeremy Hoffman; Tessa Fayers
Journal:  BMJ Case Rep       Date:  2015-05-06

4.  Isolated Conjunctival Inflammation Suggestive of IgG4-Related Disease.

Authors:  Hassan A Aziz; Alexandra Villa-Forte; Thomas P Plesec; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2015-08-26

Review 5.  IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review.

Authors:  Albert Wu; Nicholas H Andrew; Alan A McNab; Dinesh Selva
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

6.  Serum total IgG and IgG4 levels in thyroid eye disease.

Authors:  Aileen Sy; Rona Z Silkiss
Journal:  Int Med Case Rep J       Date:  2016-10-20

Review 7.  IgG4-related disease presenting as panuveitis without scleral involvement.

Authors:  Kinda Najem; Larissa Derzko-Dzulynsky; Edward A Margolin
Journal:  J Ophthalmic Inflamm Infect       Date:  2017-02-27

Review 8.  Immunoglobulin G4-related ophthalmic disease.

Authors:  Wei-Kuang Yu; Chieh-Chih Tsai; Shu-Ching Kao; Catherine Jui-Ling Liu
Journal:  Taiwan J Ophthalmol       Date:  2018 Jan-Mar

9.  Colon cancer and IgG4-related disease with orbital inflammation and bilateral optic perineuritis: A case report.

Authors:  Stephanie Lemaitre; Gemma Mateu Esquerda; Antoni Castro Guardiola; Jordi Teruel Agustin; Nicolae Sanda; Miguel González-Candial
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

10.  IgG4-related disease presenting as recurrent scleritis combined with optic neuropathy.

Authors:  Su Jin Kim; Seung Uk Lee; Min Seung Kang; Jung Hyo Ahn; Jonghoon Shin; Choul Yong Park; Ji Eun Lee
Journal:  BMC Ophthalmol       Date:  2021-01-05       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.